Video
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
ASRS 2025: 48-month results from OAKS, DERBY, and GALE open-label extension
3 Things You Should Know About Interventional Glaucoma Comanagement
Cosmetic procedures associated with serious ophthalmologic complications
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Q&A: Michael Lai, MD, PhD, on the impact of underfunding the Good Days program
Viridian partners with Kissei Pharmaceutical to develop thyroid eye disease therapies in Japan